

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | alpha-linolenic acid metabolic process (GO:0036109) | 4.20763983 |
| 2 | low-density lipoprotein particle clearance (GO:0034383) | 4.16980340 |
| 3 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.14837386 |
| 4 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.07597751 |
| 5 | regulation of sequestering of triglyceride (GO:0010889) | 4.07133663 |
| 6 | acyl-CoA biosynthetic process (GO:0071616) | 4.00269847 |
| 7 | thioester biosynthetic process (GO:0035384) | 4.00269847 |
| 8 | barbed-end actin filament capping (GO:0051016) | 3.97710850 |
| 9 | fatty acid elongation (GO:0030497) | 3.95155301 |
| 10 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.92926149 |
| 11 | acetyl-CoA metabolic process (GO:0006084) | 3.78861672 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.76044926 |
| 13 | L-phenylalanine catabolic process (GO:0006559) | 3.76044926 |
| 14 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.75233832 |
| 15 | fatty acid beta-oxidation (GO:0006635) | 3.73905519 |
| 16 | fatty acid transmembrane transport (GO:1902001) | 3.70037154 |
| 17 | biotin metabolic process (GO:0006768) | 3.64342729 |
| 18 | triglyceride biosynthetic process (GO:0019432) | 3.61527066 |
| 19 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.52376433 |
| 20 | neutral lipid biosynthetic process (GO:0046460) | 3.52286198 |
| 21 | acylglycerol biosynthetic process (GO:0046463) | 3.52286198 |
| 22 | plasma lipoprotein particle clearance (GO:0034381) | 3.48916008 |
| 23 | fatty acid catabolic process (GO:0009062) | 3.48720590 |
| 24 | short-chain fatty acid metabolic process (GO:0046459) | 3.40571454 |
| 25 | fatty acid oxidation (GO:0019395) | 3.40534376 |
| 26 | very long-chain fatty acid metabolic process (GO:0000038) | 3.40510824 |
| 27 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.39113037 |
| 28 | L-phenylalanine metabolic process (GO:0006558) | 3.39113037 |
| 29 | lipid oxidation (GO:0034440) | 3.38468832 |
| 30 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.37465438 |
| 31 | positive regulation of fatty acid oxidation (GO:0046321) | 3.33240361 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 3.32492714 |
| 33 | * triglyceride catabolic process (GO:0019433) | 3.31064583 |
| 34 | carnitine shuttle (GO:0006853) | 3.30140696 |
| 35 | response to dietary excess (GO:0002021) | 3.28775592 |
| 36 | central nervous system myelination (GO:0022010) | 3.28317120 |
| 37 | axon ensheathment in central nervous system (GO:0032291) | 3.28317120 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.27468226 |
| 39 | * neutral lipid catabolic process (GO:0046461) | 3.21564062 |
| 40 | * acylglycerol catabolic process (GO:0046464) | 3.21564062 |
| 41 | virion attachment to host cell (GO:0019062) | 3.21052183 |
| 42 | adhesion of symbiont to host cell (GO:0044650) | 3.21052183 |
| 43 | thioester metabolic process (GO:0035383) | 3.20237113 |
| 44 | acyl-CoA metabolic process (GO:0006637) | 3.20237113 |
| 45 | cellular ketone body metabolic process (GO:0046950) | 3.10890285 |
| 46 | monocarboxylic acid catabolic process (GO:0072329) | 3.09736383 |
| 47 | positive regulation of lipid catabolic process (GO:0050996) | 3.05684653 |
| 48 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.04721699 |
| 49 | sulfur amino acid catabolic process (GO:0000098) | 2.99192291 |
| 50 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.98055462 |
| 51 | * triglyceride metabolic process (GO:0006641) | 2.96029239 |
| 52 | adhesion of symbiont to host (GO:0044406) | 2.88635767 |
| 53 | creatine metabolic process (GO:0006600) | 2.88052661 |
| 54 | branched-chain amino acid catabolic process (GO:0009083) | 2.86623328 |
| 55 | stress fiber assembly (GO:0043149) | 2.85389378 |
| 56 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.84653896 |
| 57 | * glycerolipid catabolic process (GO:0046503) | 2.83179102 |
| 58 | complement activation, alternative pathway (GO:0006957) | 2.82542610 |
| 59 | bile acid biosynthetic process (GO:0006699) | 2.81945667 |
| 60 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.81015072 |
| 61 | triglyceride homeostasis (GO:0070328) | 2.80524189 |
| 62 | acylglycerol homeostasis (GO:0055090) | 2.80524189 |
| 63 | valine metabolic process (GO:0006573) | 2.80462329 |
| 64 | ketone body metabolic process (GO:1902224) | 2.79597075 |
| 65 | * acylglycerol metabolic process (GO:0006639) | 2.79120558 |
| 66 | protein localization to endosome (GO:0036010) | 2.78971724 |
| 67 | carnitine transmembrane transport (GO:1902603) | 2.78577899 |
| 68 | brown fat cell differentiation (GO:0050873) | 2.78364682 |
| 69 | aromatic amino acid family catabolic process (GO:0009074) | 2.77280188 |
| 70 | * neutral lipid metabolic process (GO:0006638) | 2.76676173 |
| 71 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.72725721 |
| 72 | regulation of fatty acid oxidation (GO:0046320) | 2.72671593 |
| 73 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.72296951 |
| 74 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.70885561 |
| 75 | cysteine metabolic process (GO:0006534) | 2.70571963 |
| 76 | negative regulation of lipase activity (GO:0060192) | 2.69393341 |
| 77 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.68153771 |
| 78 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.67142195 |
| 79 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.66311797 |
| 80 | amino-acid betaine transport (GO:0015838) | 2.65828098 |
| 81 | carnitine transport (GO:0015879) | 2.65828098 |
| 82 | cellular response to epinephrine stimulus (GO:0071872) | 2.65671332 |
| 83 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.64930292 |
| 84 | branched-chain amino acid metabolic process (GO:0009081) | 2.64568426 |
| 85 | response to methylmercury (GO:0051597) | 2.64505219 |
| 86 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.61993031 |
| 87 | regulation of triglyceride metabolic process (GO:0090207) | 2.61865780 |
| 88 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.60573830 |
| 89 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.60573830 |
| 90 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.60538245 |
| 91 | glycosphingolipid catabolic process (GO:0046479) | 2.59917812 |
| 92 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.59662444 |
| 93 | fibril organization (GO:0097435) | 2.59179070 |
| 94 | extracellular fibril organization (GO:0043206) | 2.58961007 |
| 95 | regulation of cholesterol metabolic process (GO:0090181) | 2.58322386 |
| 96 | regulation of macrophage chemotaxis (GO:0010758) | 2.57478764 |
| 97 | glyoxylate metabolic process (GO:0046487) | 2.57234029 |
| 98 | amino-acid betaine metabolic process (GO:0006577) | 2.57133434 |
| 99 | lipid storage (GO:0019915) | 2.56916810 |
| 100 | ethanol oxidation (GO:0006069) | 2.56723631 |
| 101 | apoptotic cell clearance (GO:0043277) | 2.56345827 |
| 102 | regulation of lipoprotein metabolic process (GO:0050746) | 2.55551634 |
| 103 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.55249440 |
| 104 | coenzyme catabolic process (GO:0009109) | 2.53746126 |
| 105 | cGMP-mediated signaling (GO:0019934) | 2.53679440 |
| 106 | bile acid metabolic process (GO:0008206) | 2.53072574 |
| 107 | succinate metabolic process (GO:0006105) | 2.52854404 |
| 108 | regulation of mononuclear cell migration (GO:0071675) | 2.52208277 |
| 109 | adenosine receptor signaling pathway (GO:0001973) | 2.51888984 |
| 110 | angiogenesis involved in wound healing (GO:0060055) | 2.51764180 |
| 111 | axon ensheathment (GO:0008366) | 2.51347155 |
| 112 | ensheathment of neurons (GO:0007272) | 2.51347155 |
| 113 | myelination (GO:0042552) | 2.51277749 |
| 114 | NADH metabolic process (GO:0006734) | 2.50297300 |
| 115 | regulation of early endosome to late endosome transport (GO:2000641) | 2.50156248 |
| 116 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.49589578 |
| 117 | regulation of cholesterol storage (GO:0010885) | 2.49172736 |
| 118 | tyrosine metabolic process (GO:0006570) | 2.49045662 |
| 119 | glycerol metabolic process (GO:0006071) | 2.47575586 |
| 120 | lysine catabolic process (GO:0006554) | 2.46973461 |
| 121 | lysine metabolic process (GO:0006553) | 2.46973461 |
| 122 | carboxylic acid catabolic process (GO:0046395) | 2.46694522 |
| 123 | organic acid catabolic process (GO:0016054) | 2.46694522 |
| 124 | positive regulation of receptor recycling (GO:0001921) | 2.46478353 |
| 125 | regulation of platelet aggregation (GO:0090330) | 2.45404188 |
| 126 | positive regulation of extracellular matrix organization (GO:1903055) | 2.45078633 |
| 127 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.44398603 |
| 128 | aspartate family amino acid catabolic process (GO:0009068) | 2.44365342 |
| 129 | lipid particle organization (GO:0034389) | 2.43987145 |
| 130 | import into cell (GO:0098657) | 2.43952873 |
| 131 | positive regulation of cholesterol efflux (GO:0010875) | 2.41838940 |
| 132 | white fat cell differentiation (GO:0050872) | 2.41802262 |
| 133 | positive regulation of macrophage cytokine production (GO:0060907) | 2.41601986 |
| 134 | negative regulation of platelet activation (GO:0010544) | 2.41538122 |
| 135 | cholesterol biosynthetic process (GO:0006695) | 2.40933669 |
| 136 | linoleic acid metabolic process (GO:0043651) | 2.40733546 |
| 137 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.40272164 |
| 138 | glutamate metabolic process (GO:0006536) | 2.40122321 |
| 139 | cyclooxygenase pathway (GO:0019371) | 2.39250295 |
| 140 | * cellular lipid catabolic process (GO:0044242) | 2.39143240 |
| 141 | 2-oxoglutarate metabolic process (GO:0006103) | 2.38799372 |
| 142 | protein heterotrimerization (GO:0070208) | 2.38366510 |
| 143 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.33773906 |
| 144 | negative regulation of lipid storage (GO:0010888) | 2.32440942 |
| 145 | glycolipid catabolic process (GO:0019377) | 2.30834754 |
| 146 | regulation of platelet activation (GO:0010543) | 2.28183862 |
| 147 | platelet aggregation (GO:0070527) | 2.28124431 |
| 148 | platelet degranulation (GO:0002576) | 2.27454820 |
| 149 | regulation of vitamin metabolic process (GO:0030656) | 2.25866289 |
| 150 | transcytosis (GO:0045056) | 2.24309609 |
| 151 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.23225175 |
| 152 | negative regulation of focal adhesion assembly (GO:0051895) | 2.22568870 |
| 153 | negative regulation of cell junction assembly (GO:1901889) | 2.22568870 |
| 154 | negative regulation of adherens junction organization (GO:1903392) | 2.22568870 |
| 155 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.22142955 |
| 156 | response to thyroid hormone (GO:0097066) | 2.19615411 |
| 157 | membrane raft organization (GO:0031579) | 2.16106795 |
| 158 | angiotensin maturation (GO:0002003) | 2.14213917 |
| 159 | regulation of cholesterol transport (GO:0032374) | 2.13693776 |
| 160 | regulation of sterol transport (GO:0032371) | 2.13693776 |
| 161 | diacylglycerol metabolic process (GO:0046339) | 2.13439150 |
| 162 | positive regulation of cholesterol transport (GO:0032376) | 2.13295984 |
| 163 | positive regulation of sterol transport (GO:0032373) | 2.13295984 |
| 164 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.13137926 |
| 165 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.12664329 |
| 166 | negative regulation of amino acid transport (GO:0051956) | 2.09921177 |
| 167 | renal filtration (GO:0097205) | 2.08174468 |
| 168 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.08168154 |
| 169 | positive regulation of lipid storage (GO:0010884) | 2.06736945 |
| 170 | glomerular filtration (GO:0003094) | 2.06479947 |
| 171 | regulation of cholesterol efflux (GO:0010874) | 2.05648242 |
| 172 | activation of MAPKKK activity (GO:0000185) | 2.05260001 |
| 173 | regulation of integrin activation (GO:0033623) | 2.04472735 |
| 174 | endothelium development (GO:0003158) | 2.03820270 |
| 175 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.03788028 |
| 176 | negative regulation of hemostasis (GO:1900047) | 2.00147169 |
| 177 | negative regulation of blood coagulation (GO:0030195) | 2.00147169 |
| 178 | regulation of vitamin D biosynthetic process (GO:0060556) | 1.99429603 |
| 179 | cortical actin cytoskeleton organization (GO:0030866) | 1.97474979 |
| 180 | actin filament capping (GO:0051693) | 1.97007087 |
| 181 | cellular response to nutrient (GO:0031670) | 1.96565784 |
| 182 | fibrinolysis (GO:0042730) | 1.95776329 |
| 183 | endocytic recycling (GO:0032456) | 1.95234356 |
| 184 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 1.95031728 |
| 185 | regulation of homotypic cell-cell adhesion (GO:0034110) | 1.94586066 |
| 186 | negative regulation of coagulation (GO:0050819) | 1.93699631 |
| 187 | regulation of macrophage cytokine production (GO:0010935) | 1.93069999 |
| 188 | positive regulation of blood coagulation (GO:0030194) | 1.93023458 |
| 189 | positive regulation of hemostasis (GO:1900048) | 1.93023458 |
| 190 | keratan sulfate catabolic process (GO:0042340) | 1.92309833 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.67116413 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.16111053 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.09027029 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.79519599 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.46557195 |
| 6 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.38613343 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.17878763 |
| 8 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.17869883 |
| 9 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.11168871 |
| 10 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.10405069 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.06419332 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.04910056 |
| 13 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.99166964 |
| 14 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.92869741 |
| 15 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.92519262 |
| 16 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.90294119 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.83553246 |
| 18 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.81129133 |
| 19 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.78594419 |
| 20 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.77103964 |
| 21 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.76986229 |
| 22 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.76986229 |
| 23 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.76361965 |
| 24 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.74231756 |
| 25 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.73107114 |
| 26 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.72104782 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.71927181 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.67414359 |
| 29 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.66795298 |
| 30 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.65194811 |
| 31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.63007875 |
| 32 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.62630728 |
| 33 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.62113653 |
| 34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.61780881 |
| 35 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.60972351 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53871953 |
| 37 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.53237539 |
| 38 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.52185881 |
| 39 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.50218727 |
| 40 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.48876641 |
| 41 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.47962821 |
| 42 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.47679184 |
| 43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44474946 |
| 44 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.44338288 |
| 45 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.42292946 |
| 46 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.40321947 |
| 47 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.38235251 |
| 48 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.37886183 |
| 49 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.37449386 |
| 50 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.35313700 |
| 51 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.34642971 |
| 52 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.34586366 |
| 53 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34089311 |
| 54 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.34067457 |
| 55 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.33726490 |
| 56 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.33475206 |
| 57 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.32877863 |
| 58 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.32775079 |
| 59 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.32612855 |
| 60 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.29201110 |
| 61 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29116331 |
| 62 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29025135 |
| 63 | KDM2B_26808549_Chip-Seq_K562_Human | 1.28117822 |
| 64 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.26904589 |
| 65 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.26067288 |
| 66 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.26003642 |
| 67 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.24030599 |
| 68 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.23485349 |
| 69 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22210535 |
| 70 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.21915943 |
| 71 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.21752581 |
| 72 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.21752581 |
| 73 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.21686263 |
| 74 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.21018610 |
| 75 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.18389070 |
| 76 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.14969682 |
| 77 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.13972434 |
| 78 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.13698600 |
| 79 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.13472003 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12833544 |
| 81 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.12578220 |
| 82 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.12500638 |
| 83 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.09629616 |
| 84 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.08712822 |
| 85 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.08321535 |
| 86 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.08149506 |
| 87 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08043379 |
| 88 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.07877071 |
| 89 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.06116664 |
| 90 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06050792 |
| 91 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.05844666 |
| 92 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.05741807 |
| 93 | SPI1_23127762_ChIP-Seq_K562_Human | 1.05558982 |
| 94 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04942888 |
| 95 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.04223221 |
| 96 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.03138998 |
| 97 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02883270 |
| 98 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02610008 |
| 99 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.02468412 |
| 100 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02347477 |
| 101 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02148894 |
| 102 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01248157 |
| 103 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00834836 |
| 104 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.00695020 |
| 105 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00476330 |
| 106 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.00306343 |
| 107 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00109414 |
| 108 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.99738825 |
| 109 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.99251478 |
| 110 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99138989 |
| 111 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98404173 |
| 112 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.97734353 |
| 113 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.97682712 |
| 114 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.97528226 |
| 115 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.97344460 |
| 116 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97336074 |
| 117 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.97019842 |
| 118 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.96280471 |
| 119 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.96106595 |
| 120 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95587349 |
| 121 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.95242853 |
| 122 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.95162989 |
| 123 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.94710601 |
| 124 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94470243 |
| 125 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94307771 |
| 126 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.94258667 |
| 127 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.94200839 |
| 128 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.93646121 |
| 129 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.93552860 |
| 130 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.92939860 |
| 131 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.91961963 |
| 132 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90109963 |
| 133 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.89192539 |
| 134 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.88698266 |
| 135 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.87690330 |
| 136 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.87679616 |
| 137 | RXR_22108803_ChIP-Seq_LS180_Human | 0.86728070 |
| 138 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.86458343 |
| 139 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.86393563 |
| 140 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.85914361 |
| 141 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.85678492 |
| 142 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.84718084 |
| 143 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.84718084 |
| 144 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.84114112 |
| 145 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.82753482 |
| 146 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.82650494 |
| 147 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80991791 |
| 148 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.80957772 |
| 149 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.80236039 |
| 150 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.80088607 |
| 151 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.79915086 |
| 152 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.78648885 |
| 153 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.78455957 |
| 154 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.78264214 |
| 155 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.77416292 |
| 156 | AR_25329375_ChIP-Seq_VCAP_Human | 0.77346504 |
| 157 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.76904960 |
| 158 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.76466514 |
| 159 | P300_19829295_ChIP-Seq_ESCs_Human | 0.76195173 |
| 160 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75875037 |
| 161 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.75756938 |
| 162 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74648402 |
| 163 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.74536262 |
| 164 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.72913989 |
| 165 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.72064855 |
| 166 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.71911547 |
| 167 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.71487433 |
| 168 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.70659393 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 4.09869882 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.60621113 |
| 3 | MP0005360_urolithiasis | 3.16412079 |
| 4 | MP0004130_abnormal_muscle_cell | 3.13896597 |
| 5 | MP0005666_abnormal_adipose_tissue | 3.02951048 |
| 6 | MP0005365_abnormal_bile_salt | 2.89791302 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 2.87736543 |
| 8 | MP0003690_abnormal_glial_cell | 2.82721347 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.76824580 |
| 10 | MP0004185_abnormal_adipocyte_glucose | 2.75381504 |
| 11 | MP0003303_peritoneal_inflammation | 2.70012437 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.69678044 |
| 13 | MP0005085_abnormal_gallbladder_physiolo | 2.56016120 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.41186920 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.32276688 |
| 16 | MP0005464_abnormal_platelet_physiology | 2.31263800 |
| 17 | MP0005375_adipose_tissue_phenotype | 2.19020001 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.13531411 |
| 19 | MP0004510_myositis | 2.11847085 |
| 20 | MP0000920_abnormal_myelination | 2.11156397 |
| 21 | * MP0002118_abnormal_lipid_homeostasis | 2.10582463 |
| 22 | MP0000343_altered_response_to | 2.10160501 |
| 23 | MP0003329_amyloid_beta_deposits | 2.06289627 |
| 24 | MP0003279_aneurysm | 2.00635001 |
| 25 | MP0002971_abnormal_brown_adipose | 1.89490972 |
| 26 | MP0008438_abnormal_cutaneous_collagen | 1.85396657 |
| 27 | MP0002876_abnormal_thyroid_physiology | 1.84653545 |
| 28 | MP0003566_abnormal_cell_adhesion | 1.80199022 |
| 29 | MP0000013_abnormal_adipose_tissue | 1.79831747 |
| 30 | MP0001958_emphysema | 1.76760469 |
| 31 | MP0005332_abnormal_amino_acid | 1.68364902 |
| 32 | MP0003806_abnormal_nucleotide_metabolis | 1.62074448 |
| 33 | MP0003011_delayed_dark_adaptation | 1.61473300 |
| 34 | MP0001661_extended_life_span | 1.59385367 |
| 35 | MP0003828_pulmonary_edema | 1.59166192 |
| 36 | MP0003879_abnormal_hair_cell | 1.57538753 |
| 37 | MP0009840_abnormal_foam_cell | 1.55611996 |
| 38 | MP0003436_decreased_susceptibility_to | 1.55428449 |
| 39 | MP0003950_abnormal_plasma_membrane | 1.52799308 |
| 40 | MP0005165_increased_susceptibility_to | 1.52497004 |
| 41 | MP0003091_abnormal_cell_migration | 1.51576557 |
| 42 | MP0008004_abnormal_stomach_pH | 1.50014099 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.49967339 |
| 44 | MP0002148_abnormal_hypersensitivity_rea | 1.49831433 |
| 45 | * MP0005535_abnormal_body_temperature | 1.46094692 |
| 46 | MP0000604_amyloidosis | 1.45557152 |
| 47 | MP0005023_abnormal_wound_healing | 1.44795150 |
| 48 | MP0002998_abnormal_bone_remodeling | 1.41776165 |
| 49 | MP0006082_CNS_inflammation | 1.40405045 |
| 50 | MP0004859_abnormal_synaptic_plasticity | 1.40029727 |
| 51 | MP0000003_abnormal_adipose_tissue | 1.39987583 |
| 52 | MP0005334_abnormal_fat_pad | 1.38600499 |
| 53 | MP0005166_decreased_susceptibility_to | 1.36310062 |
| 54 | MP0000465_gastrointestinal_hemorrhage | 1.34121321 |
| 55 | MP0009780_abnormal_chondrocyte_physiolo | 1.33894674 |
| 56 | MP0000751_myopathy | 1.32808312 |
| 57 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.32359953 |
| 58 | MP0004270_analgesia | 1.32052596 |
| 59 | MP0003300_gastrointestinal_ulcer | 1.30740739 |
| 60 | MP0005164_abnormal_response_to | 1.30509498 |
| 61 | MP0003252_abnormal_bile_duct | 1.29722082 |
| 62 | MP0003195_calcinosis | 1.25935646 |
| 63 | MP0005275_abnormal_skin_tensile | 1.23607324 |
| 64 | MP0001501_abnormal_sleep_pattern | 1.22751383 |
| 65 | MP0001542_abnormal_bone_strength | 1.22188417 |
| 66 | MP0002254_reproductive_system_inflammat | 1.21815866 |
| 67 | MP0003172_abnormal_lysosome_physiology | 1.21748649 |
| 68 | MP0003448_altered_tumor_morphology | 1.21233875 |
| 69 | MP0000858_altered_metastatic_potential | 1.20823111 |
| 70 | MP0000609_abnormal_liver_physiology | 1.20065946 |
| 71 | MP0009785_altered_susceptibility_to | 1.19881213 |
| 72 | MP0001486_abnormal_startle_reflex | 1.19352666 |
| 73 | MP0002822_catalepsy | 1.18574189 |
| 74 | MP0004147_increased_porphyrin_level | 1.18197501 |
| 75 | MP0000249_abnormal_blood_vessel | 1.18007685 |
| 76 | MP0002419_abnormal_innate_immunity | 1.15526031 |
| 77 | MP0004947_skin_inflammation | 1.14705735 |
| 78 | MP0005451_abnormal_body_composition | 1.14609034 |
| 79 | MP0003880_abnormal_central_pattern | 1.14365552 |
| 80 | MP0009115_abnormal_fat_cell | 1.10898219 |
| 81 | MP0004215_abnormal_myocardial_fiber | 1.10262637 |
| 82 | MP0005083_abnormal_biliary_tract | 1.10117890 |
| 83 | MP0004036_abnormal_muscle_relaxation | 1.09771999 |
| 84 | MP0002064_seizures | 1.09456095 |
| 85 | MP0003453_abnormal_keratinocyte_physiol | 1.08651559 |
| 86 | MP0002796_impaired_skin_barrier | 1.07110833 |
| 87 | MP0009046_muscle_twitch | 1.07050884 |
| 88 | MP0002272_abnormal_nervous_system | 1.06979120 |
| 89 | MP0001666_abnormal_nutrient_absorption | 1.06846690 |
| 90 | MP0004272_abnormal_basement_membrane | 1.05654172 |
| 91 | MP0002090_abnormal_vision | 1.05284039 |
| 92 | MP0003868_abnormal_feces_composition | 1.03293846 |
| 93 | MP0006138_congestive_heart_failure | 1.02655840 |
| 94 | MP0003075_altered_response_to | 1.02640441 |
| 95 | MP0002877_abnormal_melanocyte_morpholog | 1.02628460 |
| 96 | MP0005330_cardiomyopathy | 1.01512913 |
| 97 | MP0005025_abnormal_response_to | 1.01493172 |
| 98 | MP0005503_abnormal_tendon_morphology | 1.01107058 |
| 99 | MP0005000_abnormal_immune_tolerance | 1.00136241 |
| 100 | MP0003633_abnormal_nervous_system | 0.99333864 |
| 101 | MP0004019_abnormal_vitamin_homeostasis | 0.98832903 |
| 102 | MP0005257_abnormal_intraocular_pressure | 0.98698620 |
| 103 | MP0002295_abnormal_pulmonary_circulatio | 0.97234349 |
| 104 | MP0005620_abnormal_muscle_contractility | 0.96328692 |
| 105 | * MP0008874_decreased_physiological_sensi | 0.96260437 |
| 106 | MP0010155_abnormal_intestine_physiology | 0.96102190 |
| 107 | MP0005623_abnormal_meninges_morphology | 0.95299809 |
| 108 | MP0003635_abnormal_synaptic_transmissio | 0.95188878 |
| 109 | MP0005387_immune_system_phenotype | 0.95073087 |
| 110 | MP0001790_abnormal_immune_system | 0.95073087 |
| 111 | MP0003634_abnormal_glial_cell | 0.94863316 |
| 112 | MP0009764_decreased_sensitivity_to | 0.94852384 |
| 113 | MP0006036_abnormal_mitochondrial_physio | 0.94134052 |
| 114 | MP0005167_abnormal_blood-brain_barrier | 0.94092548 |
| 115 | MP0005448_abnormal_energy_balance | 0.93748912 |
| 116 | MP0004885_abnormal_endolymph | 0.93474021 |
| 117 | MP0003186_abnormal_redox_activity | 0.91996508 |
| 118 | MP0005319_abnormal_enzyme/_coenzyme | 0.91239432 |
| 119 | MP0000767_abnormal_smooth_muscle | 0.89906169 |
| 120 | MP0001851_eye_inflammation | 0.89414676 |
| 121 | MP0005390_skeleton_phenotype | 0.88383365 |
| 122 | MP0003045_fibrosis | 0.87410154 |
| 123 | MP0002078_abnormal_glucose_homeostasis | 0.87252061 |
| 124 | MP0003183_abnormal_peptide_metabolism | 0.87082910 |
| 125 | * MP0009745_abnormal_behavioral_response | 0.86688639 |
| 126 | MP0000685_abnormal_immune_system | 0.84862367 |
| 127 | MP0001835_abnormal_antigen_presentation | 0.83632123 |
| 128 | MP0002896_abnormal_bone_mineralization | 0.83560951 |
| 129 | MP0003631_nervous_system_phenotype | 0.83273836 |
| 130 | MP0001545_abnormal_hematopoietic_system | 0.82994317 |
| 131 | MP0005397_hematopoietic_system_phenotyp | 0.82994317 |
| 132 | MP0010368_abnormal_lymphatic_system | 0.82145168 |
| 133 | MP0002972_abnormal_cardiac_muscle | 0.81759653 |
| 134 | MP0002332_abnormal_exercise_endurance | 0.80917798 |
| 135 | MP0000230_abnormal_systemic_arterial | 0.79907945 |
| 136 | MP0000747_muscle_weakness | 0.79501950 |
| 137 | MP0004883_abnormal_blood_vessel | 0.78960580 |
| 138 | MP0003959_abnormal_lean_body | 0.77763000 |
| 139 | MP0009643_abnormal_urine_homeostasis | 0.76568856 |
| 140 | MP0002970_abnormal_white_adipose | 0.75704281 |
| 141 | MP0008775_abnormal_heart_ventricle | 0.75292533 |
| 142 | MP0000749_muscle_degeneration | 0.74613793 |
| 143 | MP0003646_muscle_fatigue | 0.74498481 |
| 144 | MP0004087_abnormal_muscle_fiber | 0.73938936 |
| 145 | MP0005595_abnormal_vascular_smooth | 0.72310441 |
| 146 | MP0001177_atelectasis | 0.71743151 |
| 147 | MP0003632_abnormal_nervous_system | 0.71557432 |
| 148 | MP0005452_abnormal_adipose_tissue | 0.71337127 |
| 149 | MP0001764_abnormal_homeostasis | 0.70945773 |
| 150 | MP0004742_abnormal_vestibular_system | 0.70416977 |
| 151 | MP0005386_behavior/neurological_phenoty | 0.69751455 |
| 152 | MP0004924_abnormal_behavior | 0.69751455 |
| 153 | MP0008569_lethality_at_weaning | 0.69166537 |
| 154 | MP0002063_abnormal_learning/memory/cond | 0.69126437 |
| 155 | MP0005647_abnormal_sex_gland | 0.68643723 |
| 156 | MP0001440_abnormal_grooming_behavior | 0.68264578 |
| 157 | MP0003724_increased_susceptibility_to | 0.68188462 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 4.28305463 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.28305463 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.28305463 |
| 4 | Hyperlipoproteinemia (HP:0010980) | 4.22929894 |
| 5 | Neurofibrillary tangles (HP:0002185) | 4.16088654 |
| 6 | Xanthomatosis (HP:0000991) | 4.06286117 |
| 7 | Hyperglycinuria (HP:0003108) | 4.05780566 |
| 8 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.90456958 |
| 9 | Abnormality of glycine metabolism (HP:0010895) | 3.90456958 |
| 10 | Purpura (HP:0000979) | 3.88189888 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 3.65928918 |
| 12 | Deep venous thrombosis (HP:0002625) | 3.62497657 |
| 13 | Protrusio acetabuli (HP:0003179) | 3.56119897 |
| 14 | Petechiae (HP:0000967) | 3.54168196 |
| 15 | Intrahepatic cholestasis (HP:0001406) | 3.48718887 |
| 16 | Increased mean platelet volume (HP:0011877) | 3.47866805 |
| 17 | Ketosis (HP:0001946) | 3.46619418 |
| 18 | Complement deficiency (HP:0004431) | 3.33989828 |
| 19 | Dysostosis multiplex (HP:0000943) | 3.32088276 |
| 20 | Cerebral inclusion bodies (HP:0100314) | 3.31842025 |
| 21 | Abnormal platelet volume (HP:0011876) | 3.19429568 |
| 22 | Epidermoid cyst (HP:0200040) | 3.18715131 |
| 23 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.14729088 |
| 24 | Acanthosis nigricans (HP:0000956) | 3.14141286 |
| 25 | Hyperammonemia (HP:0001987) | 3.12134352 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.08479345 |
| 27 | Ketoacidosis (HP:0001993) | 3.06847931 |
| 28 | Menorrhagia (HP:0000132) | 3.05839161 |
| 29 | Prolonged bleeding time (HP:0003010) | 3.05620987 |
| 30 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.05202116 |
| 31 | Premature rupture of membranes (HP:0001788) | 2.99664810 |
| 32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.97171660 |
| 33 | Hyperglycinemia (HP:0002154) | 2.96224553 |
| 34 | Vertebral compression fractures (HP:0002953) | 2.93763706 |
| 35 | Oligomenorrhea (HP:0000876) | 2.88567753 |
| 36 | Hypoglycemic coma (HP:0001325) | 2.82148078 |
| 37 | Myoglobinuria (HP:0002913) | 2.79161886 |
| 38 | Hypertriglyceridemia (HP:0002155) | 2.78418052 |
| 39 | Cerebral hemorrhage (HP:0001342) | 2.75354234 |
| 40 | Hyporeflexia of lower limbs (HP:0002600) | 2.70216314 |
| 41 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.69874921 |
| 42 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.69874921 |
| 43 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.68216811 |
| 44 | Sensory axonal neuropathy (HP:0003390) | 2.63543227 |
| 45 | Aortic aneurysm (HP:0004942) | 2.61598052 |
| 46 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.60401824 |
| 47 | Dicarboxylic aciduria (HP:0003215) | 2.60401824 |
| 48 | Amyloidosis (HP:0011034) | 2.57197543 |
| 49 | Prolonged partial thromboplastin time (HP:0003645) | 2.56031356 |
| 50 | Difficulty running (HP:0009046) | 2.55586727 |
| 51 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.52781656 |
| 52 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.52773343 |
| 53 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.52773343 |
| 54 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.52773343 |
| 55 | Distal lower limb amyotrophy (HP:0008944) | 2.52582131 |
| 56 | Mucopolysacchariduria (HP:0008155) | 2.50650722 |
| 57 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.50650722 |
| 58 | Intention tremor (HP:0002080) | 2.48987247 |
| 59 | Exercise-induced myalgia (HP:0003738) | 2.48499744 |
| 60 | Increased cerebral lipofuscin (HP:0011813) | 2.46193659 |
| 61 | Nuclear cataract (HP:0100018) | 2.46176809 |
| 62 | Hypolipoproteinemia (HP:0010981) | 2.45090624 |
| 63 | Type 1 muscle fiber predominance (HP:0003803) | 2.44174786 |
| 64 | Spinal rigidity (HP:0003306) | 2.43483934 |
| 65 | Muscle fiber splitting (HP:0003555) | 2.42280576 |
| 66 | Abnormality of glycolysis (HP:0004366) | 2.36703526 |
| 67 | Increased serum pyruvate (HP:0003542) | 2.36703526 |
| 68 | Epistaxis (HP:0000421) | 2.35954003 |
| 69 | Distal lower limb muscle weakness (HP:0009053) | 2.34402003 |
| 70 | Polycythemia (HP:0001901) | 2.34104151 |
| 71 | Hypercholesterolemia (HP:0003124) | 2.32875275 |
| 72 | Increased muscle lipid content (HP:0009058) | 2.31517196 |
| 73 | Mutism (HP:0002300) | 2.31228891 |
| 74 | Cerebral edema (HP:0002181) | 2.30357737 |
| 75 | Vacuolated lymphocytes (HP:0001922) | 2.26784580 |
| 76 | Increased connective tissue (HP:0009025) | 2.23860566 |
| 77 | Impaired platelet aggregation (HP:0003540) | 2.22806980 |
| 78 | Abnormal platelet function (HP:0011869) | 2.22806980 |
| 79 | Skin nodule (HP:0200036) | 2.20011175 |
| 80 | Asymmetric septal hypertrophy (HP:0001670) | 2.19328616 |
| 81 | Parakeratosis (HP:0001036) | 2.17798978 |
| 82 | Hemorrhage of the eye (HP:0011885) | 2.17225463 |
| 83 | Hyperventilation (HP:0002883) | 2.15087709 |
| 84 | Abnormality of the Achilles tendon (HP:0005109) | 2.14760015 |
| 85 | Achilles tendon contracture (HP:0001771) | 2.11777012 |
| 86 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.10377323 |
| 87 | Abnormality of complement system (HP:0005339) | 2.10337117 |
| 88 | Abnormality of the corticospinal tract (HP:0002492) | 2.09664988 |
| 89 | Insidious onset (HP:0003587) | 2.09402831 |
| 90 | Termporal pattern (HP:0011008) | 2.09402831 |
| 91 | Delayed CNS myelination (HP:0002188) | 2.09371179 |
| 92 | Vascular tortuosity (HP:0004948) | 2.09123629 |
| 93 | Gingival bleeding (HP:0000225) | 2.08940006 |
| 94 | Glomerulonephritis (HP:0000099) | 2.07101558 |
| 95 | Myokymia (HP:0002411) | 2.05191563 |
| 96 | Lethargy (HP:0001254) | 2.05047624 |
| 97 | Lower limb amyotrophy (HP:0007210) | 2.04822033 |
| 98 | Acute encephalopathy (HP:0006846) | 2.04419936 |
| 99 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.04077457 |
| 100 | Pheochromocytoma (HP:0002666) | 2.02791997 |
| 101 | Cerebral aneurysm (HP:0004944) | 2.02473276 |
| 102 | Loss of speech (HP:0002371) | 2.02338550 |
| 103 | Hydroxyprolinuria (HP:0003080) | 2.02170981 |
| 104 | Abnormality of proline metabolism (HP:0010907) | 2.02170981 |
| 105 | Supranuclear gaze palsy (HP:0000605) | 2.02102064 |
| 106 | Aortic dissection (HP:0002647) | 2.01965580 |
| 107 | Interstitial pulmonary disease (HP:0006530) | 2.00525667 |
| 108 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.99996121 |
| 109 | Abnormality of macrophages (HP:0004311) | 1.99011085 |
| 110 | Onion bulb formation (HP:0003383) | 1.98592461 |
| 111 | Hepatosplenomegaly (HP:0001433) | 1.98184732 |
| 112 | Hypobetalipoproteinemia (HP:0003563) | 1.97087812 |
| 113 | Methylmalonic acidemia (HP:0002912) | 1.96710718 |
| 114 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.96282552 |
| 115 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.96171990 |
| 116 | Ankle contracture (HP:0006466) | 1.96132610 |
| 117 | Bone cyst (HP:0012062) | 1.94935507 |
| 118 | Abnormal gallbladder morphology (HP:0012437) | 1.94631588 |
| 119 | Vomiting (HP:0002013) | 1.94034488 |
| 120 | Cervical subluxation (HP:0003308) | 1.93350293 |
| 121 | Distal upper limb amyotrophy (HP:0007149) | 1.92570461 |
| 122 | Upper limb amyotrophy (HP:0009129) | 1.92570461 |
| 123 | Dysmetria (HP:0001310) | 1.92303311 |
| 124 | Emphysema (HP:0002097) | 1.91048335 |
| 125 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.90497431 |
| 126 | Metabolic acidosis (HP:0001942) | 1.89582710 |
| 127 | Action tremor (HP:0002345) | 1.88109692 |
| 128 | Sudden death (HP:0001699) | 1.88052876 |
| 129 | Axonal loss (HP:0003447) | 1.86443002 |
| 130 | Increased variability in muscle fiber diameter (HP:0003557) | 1.85746659 |
| 131 | Wormian bones (HP:0002645) | 1.85026967 |
| 132 | Spastic paraparesis (HP:0002313) | 1.84271922 |
| 133 | Osteolytic defects of the hand bones (HP:0009699) | 1.83779810 |
| 134 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.83779810 |
| 135 | Hepatic necrosis (HP:0002605) | 1.83451608 |
| 136 | Cholelithiasis (HP:0001081) | 1.83297932 |
| 137 | Hyperparathyroidism (HP:0000843) | 1.81894395 |
| 138 | Polygenic inheritance (HP:0010982) | 1.81290370 |
| 139 | Pancreatitis (HP:0001733) | 1.81060571 |
| 140 | Joint stiffness (HP:0001387) | 1.80619277 |
| 141 | Brushfield spots (HP:0001088) | 1.80601777 |
| 142 | Rhabdomyolysis (HP:0003201) | 1.80515189 |
| 143 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.80513417 |
| 144 | Abnormal eating behavior (HP:0100738) | 1.79903728 |
| 145 | Abnormal gallbladder physiology (HP:0012438) | 1.79362784 |
| 146 | Cholecystitis (HP:0001082) | 1.79362784 |
| 147 | Focal motor seizures (HP:0011153) | 1.78591128 |
| 148 | Abnormality of the nasal mucosa (HP:0000433) | 1.78589190 |
| 149 | Slender build (HP:0001533) | 1.78412694 |
| 150 | Apathy (HP:0000741) | 1.78074807 |
| 151 | Myocardial infarction (HP:0001658) | 1.78050761 |
| 152 | Arterial tortuosity (HP:0005116) | 1.77370953 |
| 153 | Follicular hyperkeratosis (HP:0007502) | 1.77275687 |
| 154 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.76646470 |
| 155 | Abnormality of the periventricular white matter (HP:0002518) | 1.76401910 |
| 156 | Nephritis (HP:0000123) | 1.76050042 |
| 157 | Joint hemorrhage (HP:0005261) | 1.75719251 |
| 158 | Sensorimotor neuropathy (HP:0007141) | 1.74639912 |
| 159 | Abnormality of serum amino acid levels (HP:0003112) | 1.74486138 |
| 160 | Methylmalonic aciduria (HP:0012120) | 1.73803898 |
| 161 | Spontaneous hematomas (HP:0007420) | 1.73380295 |
| 162 | Mitral stenosis (HP:0001718) | 1.72688516 |
| 163 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.72042785 |
| 164 | Aplasia of the phalanges of the hand (HP:0009802) | 1.72042785 |
| 165 | Aplasia involving bones of the extremities (HP:0009825) | 1.72042785 |
| 166 | Dilatation of the ascending aorta (HP:0005111) | 1.71522668 |
| 167 | Aneurysm (HP:0002617) | 1.71473373 |
| 168 | Diminished motivation (HP:0000745) | 1.70654149 |
| 169 | Craniofacial dystonia (HP:0012179) | 1.70126141 |
| 170 | Fat malabsorption (HP:0002630) | 1.70037699 |
| 171 | Abnormality of methionine metabolism (HP:0010901) | 1.69863823 |
| 172 | Muscle stiffness (HP:0003552) | 1.68919065 |
| 173 | Malnutrition (HP:0004395) | 1.67381070 |
| 174 | Neuroendocrine neoplasm (HP:0100634) | 1.67189646 |
| 175 | Focal segmental glomerulosclerosis (HP:0000097) | 1.66581708 |
| 176 | Bladder diverticulum (HP:0000015) | 1.66365974 |
| 177 | Calf muscle hypertrophy (HP:0008981) | 1.60760797 |
| 178 | Pigmentary retinal degeneration (HP:0001146) | 1.60465992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 3.46980284 |
| 2 | BCKDK | 3.10274623 |
| 3 | IRAK3 | 2.66251082 |
| 4 | CAMK1D | 2.54319346 |
| 5 | CAMK1G | 2.45545781 |
| 6 | EPHA4 | 2.45200977 |
| 7 | EPHB1 | 2.36537054 |
| 8 | TESK1 | 2.30205950 |
| 9 | TRIB3 | 2.28948866 |
| 10 | RIPK4 | 2.25321125 |
| 11 | SIK1 | 2.22649342 |
| 12 | OXSR1 | 2.20358263 |
| 13 | TGFBR2 | 1.98401693 |
| 14 | FGFR2 | 1.85908419 |
| 15 | PDGFRA | 1.85627109 |
| 16 | TIE1 | 1.75481511 |
| 17 | WNK4 | 1.72699880 |
| 18 | LMTK2 | 1.69937005 |
| 19 | PHKG2 | 1.67133839 |
| 20 | PHKG1 | 1.67133839 |
| 21 | PDK3 | 1.66621988 |
| 22 | PDK4 | 1.66621988 |
| 23 | TAOK2 | 1.65005554 |
| 24 | MST1R | 1.64836054 |
| 25 | TBK1 | 1.64071244 |
| 26 | NTRK1 | 1.63725979 |
| 27 | MET | 1.60663333 |
| 28 | TNIK | 1.58433374 |
| 29 | MAP3K11 | 1.57772032 |
| 30 | PIM2 | 1.46322876 |
| 31 | MOS | 1.45419927 |
| 32 | PDK2 | 1.44574354 |
| 33 | PKN1 | 1.39340340 |
| 34 | CDC42BPA | 1.37261199 |
| 35 | MAP3K3 | 1.37065545 |
| 36 | LIMK1 | 1.35185310 |
| 37 | PINK1 | 1.34461943 |
| 38 | LATS2 | 1.33322821 |
| 39 | PAK6 | 1.32568903 |
| 40 | INSRR | 1.30271257 |
| 41 | NEK9 | 1.29037570 |
| 42 | ICK | 1.28947553 |
| 43 | TYRO3 | 1.26916199 |
| 44 | PDPK1 | 1.25791398 |
| 45 | GRK7 | 1.24940423 |
| 46 | MAP3K13 | 1.20849575 |
| 47 | DAPK2 | 1.19023465 |
| 48 | MAP2K3 | 1.17436376 |
| 49 | BCR | 1.17151140 |
| 50 | MYLK | 1.15150907 |
| 51 | PIK3CA | 1.13253294 |
| 52 | TYK2 | 1.12857491 |
| 53 | NME2 | 1.12538252 |
| 54 | PRKD3 | 1.12288056 |
| 55 | KSR2 | 1.11942271 |
| 56 | PRKAA2 | 1.11329190 |
| 57 | PTK2 | 1.10122157 |
| 58 | PTK2B | 1.09908416 |
| 59 | BMX | 1.07528076 |
| 60 | MAP3K14 | 1.07102279 |
| 61 | KIT | 1.05008076 |
| 62 | MAP2K4 | 1.02777906 |
| 63 | EPHA2 | 1.02433674 |
| 64 | PRPF4B | 1.01412754 |
| 65 | ZAP70 | 1.00937920 |
| 66 | DAPK3 | 1.00264888 |
| 67 | PAK3 | 0.99514535 |
| 68 | MAPKAPK3 | 0.99106426 |
| 69 | JAK1 | 0.98965014 |
| 70 | WNK1 | 0.96246552 |
| 71 | SGK494 | 0.95467961 |
| 72 | SGK223 | 0.95467961 |
| 73 | PBK | 0.93166808 |
| 74 | MAPKAPK5 | 0.90698807 |
| 75 | PAK2 | 0.89734476 |
| 76 | PRKG2 | 0.89513112 |
| 77 | PDK1 | 0.87650798 |
| 78 | FGR | 0.87489709 |
| 79 | MAPK4 | 0.85794822 |
| 80 | MAP3K1 | 0.85019662 |
| 81 | CDK5 | 0.84854544 |
| 82 | ERBB4 | 0.84842581 |
| 83 | CASK | 0.84723070 |
| 84 | PRKD1 | 0.84198087 |
| 85 | TESK2 | 0.83294835 |
| 86 | MAP3K2 | 0.82489322 |
| 87 | MAPK12 | 0.81119817 |
| 88 | OBSCN | 0.80408907 |
| 89 | RIPK1 | 0.77855228 |
| 90 | BMPR2 | 0.76235944 |
| 91 | FGFR4 | 0.76086558 |
| 92 | MAP2K1 | 0.75963274 |
| 93 | ROCK2 | 0.75383547 |
| 94 | PRKD2 | 0.73818041 |
| 95 | PRKCH | 0.73054664 |
| 96 | NTRK3 | 0.72929327 |
| 97 | RET | 0.71498972 |
| 98 | TAOK1 | 0.71481410 |
| 99 | NTRK2 | 0.71473639 |
| 100 | FES | 0.70890708 |
| 101 | GRK5 | 0.70627987 |
| 102 | PAK4 | 0.70588544 |
| 103 | NEK6 | 0.70235982 |
| 104 | CAMKK1 | 0.69596820 |
| 105 | CAMK2D | 0.69295751 |
| 106 | CAMK2G | 0.69253529 |
| 107 | MATK | 0.68302885 |
| 108 | PRKCE | 0.68241678 |
| 109 | BLK | 0.67756736 |
| 110 | CAMK2A | 0.67645986 |
| 111 | TTN | 0.66896780 |
| 112 | MARK2 | 0.66817048 |
| 113 | FER | 0.66481838 |
| 114 | PRKCQ | 0.65374877 |
| 115 | ILK | 0.63547331 |
| 116 | ABL2 | 0.63472276 |
| 117 | MAPK7 | 0.63293204 |
| 118 | DMPK | 0.63178072 |
| 119 | MAP3K4 | 0.63167999 |
| 120 | CAMK1 | 0.62247397 |
| 121 | TRPM7 | 0.61620718 |
| 122 | IRAK2 | 0.61274396 |
| 123 | EPHB2 | 0.60711397 |
| 124 | JAK3 | 0.59513964 |
| 125 | RPS6KA2 | 0.59245185 |
| 126 | CAMK2B | 0.58754003 |
| 127 | PRKACG | 0.58648338 |
| 128 | PDGFRB | 0.58014402 |
| 129 | CAMKK2 | 0.57407497 |
| 130 | DDR2 | 0.56409316 |
| 131 | ERN1 | 0.56200183 |
| 132 | IKBKB | 0.55881717 |
| 133 | GSK3A | 0.55112872 |
| 134 | MAP3K9 | 0.54629325 |
| 135 | STK38 | 0.54315589 |
| 136 | MAP3K7 | 0.54125644 |
| 137 | CSF1R | 0.54057728 |
| 138 | FYN | 0.53696100 |
| 139 | MUSK | 0.50222295 |
| 140 | CSNK1G2 | 0.49493095 |
| 141 | IKBKE | 0.49374207 |
| 142 | MINK1 | 0.47912498 |
| 143 | JAK2 | 0.47765362 |
| 144 | ROCK1 | 0.47743503 |
| 145 | ARAF | 0.47671072 |
| 146 | CSK | 0.47309209 |
| 147 | STK11 | 0.47283014 |
| 148 | DAPK1 | 0.46935139 |
| 149 | SYK | 0.46272258 |
| 150 | PRKAA1 | 0.46199458 |
| 151 | CSNK1G1 | 0.45394036 |
| 152 | PIK3CG | 0.44702307 |
| 153 | IRAK1 | 0.44510013 |
| 154 | PAK1 | 0.44458992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.06360052 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.98600078 |
| 3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.82124622 |
| 4 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.76771324 |
| 5 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.69035664 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.66270972 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.61423794 |
| 8 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.57566597 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.54627569 |
| 10 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.48457946 |
| 11 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.46803863 |
| 12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.34576939 |
| 13 | Other glycan degradation_Homo sapiens_hsa00511 | 2.31831622 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.96733350 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.90126759 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 1.80351730 |
| 17 | Lysosome_Homo sapiens_hsa04142 | 1.76820886 |
| 18 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.76548363 |
| 19 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.75131720 |
| 20 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.70271147 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.70005853 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.65873351 |
| 23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.60071219 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.57457567 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.53804850 |
| 26 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.52977715 |
| 27 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.47962928 |
| 28 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.45530056 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.39665723 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.36488094 |
| 31 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.36108120 |
| 32 | Pertussis_Homo sapiens_hsa05133 | 1.34128777 |
| 33 | * Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.33558978 |
| 34 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.30339703 |
| 35 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.28079167 |
| 36 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.25993921 |
| 37 | Platelet activation_Homo sapiens_hsa04611 | 1.23974699 |
| 38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.23448956 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20787537 |
| 40 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.18477291 |
| 41 | Histidine metabolism_Homo sapiens_hsa00340 | 1.18363305 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.18093242 |
| 43 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.15297725 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.14406475 |
| 45 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.13863917 |
| 46 | Malaria_Homo sapiens_hsa05144 | 1.13475133 |
| 47 | Amoebiasis_Homo sapiens_hsa05146 | 1.13347326 |
| 48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.11166397 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10835228 |
| 50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.09213793 |
| 51 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.08824296 |
| 52 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.06725944 |
| 53 | Focal adhesion_Homo sapiens_hsa04510 | 1.04495567 |
| 54 | Bile secretion_Homo sapiens_hsa04976 | 1.04388738 |
| 55 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.02720555 |
| 56 | Leishmaniasis_Homo sapiens_hsa05140 | 1.00913670 |
| 57 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.97767969 |
| 58 | Asthma_Homo sapiens_hsa05310 | 0.96304202 |
| 59 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.95790637 |
| 60 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95307623 |
| 61 | Retinol metabolism_Homo sapiens_hsa00830 | 0.94653919 |
| 62 | Salmonella infection_Homo sapiens_hsa05132 | 0.94374902 |
| 63 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.93841563 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.92578500 |
| 65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.91847347 |
| 66 | Allograft rejection_Homo sapiens_hsa05330 | 0.91706505 |
| 67 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.88932597 |
| 68 | Phagosome_Homo sapiens_hsa04145 | 0.88681813 |
| 69 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.88592127 |
| 70 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.86667695 |
| 71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.86461976 |
| 72 | Tuberculosis_Homo sapiens_hsa05152 | 0.85405992 |
| 73 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.84854692 |
| 74 | ABC transporters_Homo sapiens_hsa02010 | 0.84078725 |
| 75 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.83665268 |
| 76 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.82620125 |
| 77 | Mineral absorption_Homo sapiens_hsa04978 | 0.81240544 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.80214639 |
| 79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79135857 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.79048439 |
| 81 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78378555 |
| 82 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.78374051 |
| 83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77668947 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.77593440 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.75609177 |
| 86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.72135252 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.71312571 |
| 88 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.70753135 |
| 89 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.70426822 |
| 90 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.68845976 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.68799776 |
| 92 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.67809460 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67702810 |
| 94 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.66881724 |
| 95 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.65477625 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.64818909 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64244488 |
| 98 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.63927684 |
| 99 | Endocytosis_Homo sapiens_hsa04144 | 0.63538900 |
| 100 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.62691521 |
| 101 | Alzheimers disease_Homo sapiens_hsa05010 | 0.62550258 |
| 102 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.62243004 |
| 103 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.61803833 |
| 104 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.61714430 |
| 105 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.61242944 |
| 106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.61137292 |
| 107 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.60700627 |
| 108 | Long-term potentiation_Homo sapiens_hsa04720 | 0.60431468 |
| 109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.58613327 |
| 110 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.58057696 |
| 111 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57737470 |
| 112 | GABAergic synapse_Homo sapiens_hsa04727 | 0.57687672 |
| 113 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57500399 |
| 114 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57282716 |
| 115 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.57040009 |
| 116 | Renin secretion_Homo sapiens_hsa04924 | 0.55430907 |
| 117 | Parkinsons disease_Homo sapiens_hsa05012 | 0.54680025 |
| 118 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.54660601 |
| 119 | Viral myocarditis_Homo sapiens_hsa05416 | 0.54179768 |
| 120 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.53145053 |
| 121 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52310084 |
| 122 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51831670 |
| 123 | Salivary secretion_Homo sapiens_hsa04970 | 0.50000818 |
| 124 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.49390613 |
| 125 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.49272279 |
| 126 | Shigellosis_Homo sapiens_hsa05131 | 0.48738040 |
| 127 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48133541 |
| 128 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.48060924 |
| 129 | Influenza A_Homo sapiens_hsa05164 | 0.47734739 |
| 130 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.46053945 |
| 131 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.42464859 |
| 132 | Insulin resistance_Homo sapiens_hsa04931 | 0.42136118 |
| 133 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.39668895 |
| 134 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.37680806 |
| 135 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.36279745 |
| 136 | Sulfur relay system_Homo sapiens_hsa04122 | 0.36255366 |
| 137 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.36059668 |
| 138 | Morphine addiction_Homo sapiens_hsa05032 | 0.33508090 |
| 139 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.32822958 |
| 140 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.32688163 |
| 141 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.32489890 |
| 142 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.31676922 |
| 143 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.30988292 |
| 144 | Axon guidance_Homo sapiens_hsa04360 | 0.30540396 |
| 145 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.30339265 |
| 146 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.30335024 |
| 147 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29710582 |
| 148 | Prion diseases_Homo sapiens_hsa05020 | 0.28936702 |
| 149 | Circadian entrainment_Homo sapiens_hsa04713 | 0.28579282 |
| 150 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.28390224 |
| 151 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.27573086 |
| 152 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.27000163 |
| 153 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.23813189 |
| 154 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.22434736 |
| 155 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.21877520 |
| 156 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.20540844 |
| 157 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.20400165 |
| 158 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.19833790 |
| 159 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.19089820 |
| 160 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.18896147 |
| 161 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.18656452 |
| 162 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.18545200 |

